Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angiotensin II vs Vasopressin in Septic Shock
NCT05193370Phase 4Withdrawn
- Sponsor
- The University of New Mexico
- Start
- Jan 2022
- Primary completion
- Nov 2022
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Angiotensin II in septic shock, sponsored by The University of New Mexico. Planned start Jan 2022; status: withdrawn.
02
Drugs
Angiotensin II
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT05193370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05193370.